The COVID-19 pandemic: Ongoing Nordic efforts and R&D

The partners in Pandemic Antiviral Discovery (PAD) initiative has announced grants totalling more than USD 26 million for 14 research projects aimed at facilitating early-stage development of drugs to treat

AstraZeneca’s COVID-19 vaccine, Vaxzevria, has been granted full Marketing Authorisation (MA) in the European Union (EU). Vaxzevria was originally granted a conditional Marketing Authorisation (cMA) due to the urgency of the

Evusheld, a long-acting antibody combination, has been approved in the European Union (EU) for the treatment of adults and adolescents with COVID-19 who do not require supplemental oxygen and who

Researchers at Karolinska Institutet are developing a coronavirus vaccine designed to be less sensitive to mutations and equipped for future strains. The vaccine showed promising results in mice in a

Two ongoing research studies funded by NordForsk are providing new knowledge about COVID-19 related to pregnancy and mental health. The Nordic countries have similar welfare systems, access to high-quality health

Bavarian Nordic has provided an update on the Phase 3 development of ABNCoV2, a VLP-based, non-adjuvanted COVID-19 booster vaccine candidate. The upcoming Phase 3 trial has been redesigned to include

New research from Karolinska Institutet shows that a booster shot of mRNA vaccine to individuals who have received two doses of inactivated vaccine offers the same level of protection against

Several months after COVID-19, one is still at an increased risk of blood clot and bleeding, shows research from Umeå University. The researchers analyzed all COVID-19 cases in Sweden from the

Residential exposure to ambient air pollutants is linked to an elevated risk of SARS-CoV-2 infection, an observational study of young adults in Stockholm, Sweden shows. The study was conducted by

Professor Trine Hyrup Mogensen from Aarhus University will study why some people suffer from serious COVID-19 infections, while others do not become ill at all, even when exposed to massive

Researchers at Karolinska Institutet have developed a new strategy for identifying potent miniature antibodies, so-called nanobodies, against emerging SARS-CoV-2 variants. The approach led to the discovery of multiple nanobodies that

Sweden’s Minister of Health and Social Affairs, Lena Hallengren, has officially inaugurated Valneva Sweden’s new COVID-19 vaccine manufacturing facility, the first and only one of its kind in Sweden. “The

KeyPlants has shipped a first-of-its-kind vaccine manufacturing filling facility to Senegal in West Africa. After the facility is installed and becomes fully operational later in 2022, it will be the

AstraZeneca’s Evusheld, a long-acting antibody combination, has been granted marketing authorization in the European Union (EU) for the pre-exposure prophylaxis (prevention) of COVID-19 in a broad population of adults and

AstraZeneca’s Evusheld, a long-acting antibody combination, has been recommended for marketing authorization in the EU for the pre-exposure prophylaxis (prevention) of COVID-19 in a broad population of adults and adolescents

Researchers have developed a nasal spray to protect vulnerable people from not only COVID-19 but also from infection with several other viruses. The new treatment formulation that is being tested